|
Meeting Homepage
Registrants Only Area
Speaker Bios
Meeting Committee
Welcome
Registration:
Registration Info
Register
Meeting Program:
Schedule at a Glance
Workshops at a Glance
Add-on Seminars
Plenary Sessions
Mini-Plenary Sessions
Workshops
PDS Workshops
CLE
Additional Events:
International Delegates Meeting
Networking Events
Tech Fair
Tours
Accompanying Persons
Sponsors:
Meeting Sponsors
Sponsorship Opportunities
Power Networking
Miscellaneous Info:
Hotel
Weather and Dress
All About Chicago
Chicago:
Audio Tours >>
|
Speaker Biographies
Christopher Ainsley
Mr. Ainsley is responsible for overall leadership of The Patent Board, including business development and growth opportunities. He joined The Patent Board from Lexis Nexis, where he was senior vice president, global strategy and business development, accountable for strategic acquisition and divestiture at this $2.5 billion division of Reed Elsevier. Prior to that role, he was president and chief executive officer of Wolters Kluwer Health, an $800 million information and publishing company. He spent eleven years with Wolters Kluwer, first joining its tax publishing business, CCH, as vice president of strategy. Ainsley assumed positions of increasing responsibility in business development, strategy, and general management with CCH and Wolters Kluwer, in both the United States and Europe. He also spent a number of years in senior consulting roles with Arthur Andersen, Boston Consulting Group and Booz Allen & Hamilton. Ainsley holds a M.A. in Geography from Oxford University (Christ Church), and an M.B.A from Harvard Business School.
Robert Alltop
Robert Alltop, Vice President and head of CRA's Transfer Pricing Practice, focuses on transfer pricing analyses and valuations for automotive industrial, pharmaceutical, and consumer product clients. His work has been conducted within the context of IRS audits; international, state, and local tax planning; intellectual property litigation; export tax credits; and other tax and business planning projects. Mr. Alltop has previous professional experience within the automotive, pharmaceutical, medical device, consumer products, equipment manufacturing, and financial services industries. He was a managing director in KPMG LLP's Global Transfer Pricing Services practice and a senior staff member at National Economic Research Associates in Washington, D.C. Prior to that, Mr. Alltop served as an economics and public policy intern at the Center for Governmental Research in Rochester, New York.
[back to top]
Gloria Archuleta
Gloria Archuleta joined Fluid Innovation Group, a start-up firm specializing in software commercialization in 2006 after spending eight years with Cingular Wireless and SBC (now AT&T). Gloria was founder and Director of Intellectual Property for Cingular Wireless. Previously, at SBC she was responsible for all inbound technology licensing for the CTO group at Pacific Bell Wireless. Gloria earned her Bachelors degree at UCLA and her J.D. at Northwestern School of Law. Gloria is active in LES, the California Bar and the American Bar Association's IP section where she currently serves as co-chair of committee for Software Development & Licensing.
[back to top]
Mark C. Bach
Mark C. Bach is a U.S. Patent Attorney registered in Illinois and Wisconsin. Mark has a degree in Physics and Applied Mathematics from Northwestern University. For ten years, he was a Professor in the Department of Civil Engineering at Northwestern. Mark held positions with various private law firms in Chicago until he joined Abbott Laboratories as Counsel in 1993. In 2000, he became Chief Patent Counsel for Snap-on Incorporated where Mark coordinated all intellectual property activities worldwide. In 2007, Mark joined the private law firm of Rosenbaum and Associates where he continues to practice various aspects of intellectual property law.
[back to top]
Stephen J. Baggott
Stephen J. Baggott is currently Director, External Business Development with The Procter & Gamble Company. In this capacity, Steve is responsible for overseeing the Company's external commercialization, business development and intellectual asset licensing activities for the Beauty global business unit. Steve also oversees related external business development efforts in Western Europe, and the Company's global trademark licensing program.
Procter & Gamble, headquartered in Cincinnati, Ohio, is a leading consumer products company, with sales approaching $80 billion. After graduating from Dartmouth College in 1983, Steve joined P&G in marketing/brand management. Since then, he has held various marketing positions in P&G's beauty and health businesses in both the U.S. and Europe. Steve joined P&G's External Business Development group just after its inception in 1997.
Steve is a member of the Licensing Executives Society; he sits on the Board of the Sunny Delight Beverages Company; and is involved in a number of church and community activities. A native of Anaheim, California, he resides in Blue Ash, Ohio, with his wife and two sons.
[back to top]
Raj Bawa
Dr. Raj Bawa, a biochemist and microbiologist, is President of Bawa Biotechnology Consulting LLC, a biotechnology and patent law firm founded in 2002 and based in Ashburn, Virginia. He is a registered patent agent licensed to practice before the US Patent and Trademark Office (PTO) and specializes in all aspects of biotechnology, nanotechnology and pharmaceutical patent law, including prosecution, patent strategy, application drafting, prior art searching, freedom-to-operate searching and technology research opinions. Currently, Dr. Bawa is an Adjunct Associate Professor at Rensselaer Polytechnic Institute in Troy, New York, where since 1998, he has lectured in numerous courses, including biotechnology, HIV/AIDS, microbiology, immunology and biodefense. He is also an Advisor/Patent Agent to the Office of Technology Commercialization at Rensselaer. Additionally, since 2003, he has been an Adjunct Professor of Natural and Applied Sciences at the Extended Learning Institute of Northern Virginia Community College in Annandale, Virginia. Previously he held various positions at the PTO, including Primary Examiner (6 years), Supervisory Patent Examiner (acting), and Instructor at the US Patent Academy. Dr. Bawa has served as a NIH grant reviewer, participated in NSF's merit review process and reviewed classified grant proposals from the Science Centers Program of the US Department of State. He is the author of over 50 scientific, legal and business publications. He is a Life Member of Sigma Xi, a Fellow and Board Member of the American Academy of Nanomedicine, and serves on the Global Advisory Council of the World Future Society. Presently, he serves on the editorial boards of the peer-reviewed journals, International Journal of Nanomedicine and Nanotechnology Law and Business. He is an Associate Editor of the peer-reviewed journal, Nanomedicine: Nanotechnology, Biology and Medicine. Some of Dr. Bawa's awards include: Talbot Travel Award of the US Biophysical Society (1988); Research Fellowship and Teaching Assistantship from Rensselaer (1985-90); Appreciation Award from the Under Secretary of Commerce, US Department of Commerce (2001); Service Recognition from the American Society for Microbiology (2006); Director's Award (2001) and Key Award (2005) from Rensselaer's Office of Alumni Relations.
[back to top]
Louis P. Berneman
Lou Berneman is an experienced business development executive and entrepreneur. Lou is currently the Principal of Texelerate, a consultancy specializing in technology transfer focused on royalty monetization, licensing, and creating and investing in start up ventures.
From 1995-2005, Dr. Berneman was Managing Director of the Center for Technology Transfer (CTT) at the University of Pennsylvania.
Berneman is a Past President of the Association of University Technology Managers (AUTM) and a former Vice President and Trustee of the Licensing Executives Society (LES USA & Canada). Dr. Berneman is the recipient of the LES Barnes Mentoring Award, service award from the Pennsylvania Biotechnology Association, and Award of Excellence from the Association of University Research Parks.
Lou holds a baccalaureate degree in history from the Pennsylvania State University, a teaching credential from University of California at Santa Barbara, and masters and doctoral degrees in education from Teachers College, Columbia University.
[back to top]
Rick Bero
Rick Bero is the Managing Director of CFA-LLC's Litigation and Valuation services practice and is a co-founder of CFA-LLC.
Rick provides financial and accounting consulting services and expert testimony pertaining to financial damages issues with an emphasis on intellectual property litigation.
Rick has testified approximately 80 times in trials, depositions, arbitrations and bankruptcy hearings, in his more than 20 year career.
Prior to founding CFA-LLC Rick was the Wisconsin Practice Leader for a Big 4 Accounting Firm's National Litigation & Claims Services practice.
Rick received his BBA in Accounting and Finance from the University of Wisconsin - Madison. Rick is a licensed Certified Public Accountant Accredited in Business Valuation, and a Certified Valuation Analyst.
Rick is active in numerous professional organizations, including; LES (Co-Chair of the Wisconsin Chapter since 2006, IPO, WICPA and the AICPA. Rick has co-developed and taught the IP valuation and damages Course for NACVA.
[back to top]
J. Donald Best
Education:
University of Wisconsin (M.A. 1987; J.D. 1989; Editor-In-Chief, Wisconsin Law Review)
Honors/Awards:
- Selected as one of The Best Lawyers in America 2006-2008
- Named Wisconsin Super Lawyer 2006-2007
Don is Chair of MB&F's Intellectual Property Litigation Group. He has many years' experience handling complex, high profile IP cases for clients in a wide variety of industry sectors, including biotechnology, telecommunications, mechanical arts, pharmaceuticals, computer products and medical devices.
Don has litigated major cases throughout the U.S. , and also frequently counsels clients on IP matters in Europe and Asia.
Don has been lead counsel to several major corporations, including AT&T, Ingersoll-Rand, Harley-Davidson and Promega Corporation.
Prior to joining MB&F, Don practiced for five years with a large California law firm. He is admitted to practice in Wisconsin, California, numerous District Courts, the Federal Circuit, and the U. S. Supreme Court.
[back to top]
Alaya Bettaieb
Mr. Alaya Bettaieb, graduated in physics, engineering and economics from Tunisian, US and Japanese universities. He is a known venture capitalist in MENA, former chairman of Tunisian Venture Capital Association, and acting SG of the Arab Venture Capital Association. He cumulated for the last 10 years a good track record in venture/seed funds management in MENA and is managing since 2006 several corporate venture funds within Tunisia's public and private groups. Mr. Bettaieb is behind several reforms in the VC & PE sector in Maghreb and the initiator of seed funding in Tunisia. He gained the trust of the US government to conduct a training program for young VC professionals in Algeria and to lead a regional Innovation program launched in 2005 to value Technology in Innovative SMIs in Maghreb. He is guest speaker at several international conferences dealing with Venture Capital issues in general and financing high value added technology start-ups in particular. Mr. Bettaieb is pioneer in Introducing Intellectual Property & Technology Transfer related issues to the VC community in MENA.
[back to top]
Peter Haring Bolívar
Peter Haring Bolívar was born in Mexico City, Mexico in 1969. He studied 1987-1992 electrical engineering at the RWTH Aachen University, Aachen, Germany. During his thesis, he made the first observation of Bloch oscillations, a fundamental phenomenon predicted since the beginnings of the 20th century. 1992-93 he was head of the Rescue Equipment division at Nautica Diesel Europea in Mexico-City. He worked 1993-1996 as a scientific assistant at the Institut für Halbleitertechnik II of the RWTH Aachen on conjugated polymers and femto-second dynamics in semicoductors. His Ph.D. work was awarded with a Heinrich Hertz fellowship from the science and research ministry of the state of Northrhine-Westfalia and the Wilhelm Borchers medallion of the RWTH Aachen. From 1997-2001 he was head of ultrahigh-frequency research at the Institut of Semiconductor Electronics at the RWTH Aachen where he directed applied and fundamental scien-ti-fic research on coherent Terahertz spectroscopy, and ultra-high-frequency optical characterization of electronic GHz-devices. From 2001-2004 he was head of research at the same institution with ample activities in the fields of optoelectronics, ultrafast science, ultrahigh frequency devices, optical data storage and nanotechnology, earning the Friedrich Wilhelm price of the RWTH Aachen. Currently he is head of the Institute for High Frequency and Quantum Electronics at the University of Siegen. In this year, he additionally became Vice-Rector for Research of this University. He holds three patents, five book contributions and over 70 peer-review publications.
[back to top]
Russell Boltwood
Russell Boltwood joined UTStarcom in December 1997 as its first Director of Law and Human Resources. He oversaw the Company's legal and human resources functions through its successful IPO in 2000, as well as through its expansion into India, Japan, Europe and South America. In 2007, Russell became the Company's first Vice President of Licensing and Intellectual Property, and presently oversees the Company's patent and intellectual property licensing matters. Russell holds a B.A. in Economics from the University of California, Berkeley, a J.D. from Golden Gate University in San Francisco, and is a graduate of the Executive Program at Stanford University's Graduate School of Business in Palo Alto, California. Russell is a member of the State Bar of California, and has authored a number of articles regarding intellectual property, including "Basic Patent Law in Brazil, And Recent Developments," an article published in the January 2008 edition of the International In-House Counsel Journal (www.iicj.net). Russell also provides regular comment on IP development and management issues via his blog at www.ip-transactions.typepad.com.
[back to top]
Ben Bonifant
Ben Bonifant is an experienced consultant to leaders of global pharmaceuticals and biotechnology organizations and to decision makers of large private equity funds. Mr. Bonifant has been a management consultant for more than fourteen years. His perspectives on developments in the life sciences market are frequently published in industry and strategy journals. Recent by-lined articles have appeared in Pharmaceutical Executive, Chemical Specialties, and Business Horizons. He is the author of the chapter, "Market Segmentation and New Product Development" in the recent update to The PDMA Handbook of New Product Development. In addition, Mr. Bonifant has written case studies on the pharmaceutical industry used in graduate business programs. He has been a guest lecturer at the Fuqua School of Business, the Indiana University Kelly School of Business, and many industry conferences in the US and Europe. Mr. Bonifant earned an M.B.A. from the Stanford Graduate School of Business and a B.S. in mechanical engineering from Duke University.
[back to top]
V. Walter Bratic
Mr. Bratic has extensive experience in a broad range of intellectual property subject matter. He has performed valuations and conducted licensing negotiations and strategic management studies involving intellectual property for corporate clients including multinational and international joint ventures, start-up and development stage companies. He has performed research and analysis regarding industry dynamics and IP management practices, portfolio optimization, evaluation of corporate IP strategies, and effects of technology investment, innovation, adoption and transfer on competition. He has also analyzed industry standard setting and related licensing practices. Mr. Bratic has testified in federal and state court, ICC, ITC and AAA proceedings related to intellectual property issues, including: economic, financial, accounting and business matters as they relate to damages, technology trends and industry licensing practices. Mr. Bratic has also addressed, and testified to, antitrust and competition, standard setting and patent misuse issues in various cases. Mr. Bratic has also served as a court appointed expert and consultant on valuation and damages issues. His education includes a B.A., University of Pennsylvania. Phi Beta Kappa; Summa Cum Laude and an M.B.A., Wharton Graduate School, University of Pennsylvania. He is a member of the American Institute of Certified Public Accountants.
[back to top]
Deborah W. Brooks
Deborah W. Brooks is co-founder of The Michael J. Fox Foundation for Parkinson's Research (MJFF). As such, Ms. Brooks spearheads principal-gifts fundraising and advises on strategic and programmatic direction. In addition, she serves as the senior spokesperson for new and existing external audiences.
Ms. Brooks served as MJFF's president and chief executive officer from October 2000 to February 2007, during which period the Foundation funded over $90 million in research either directly or through partnerships and became the single largest funder of Parkinson's disease research outside the U.S. government.
Prior to co-founding MJFF with actor and Parkinson's advocate Michael J. Fox, Ms. Brooks spent nine years at Goldman, Sachs & Co. as vice president in the Fixed Income and Asset Management Divisions. Seeking to apply her strategic background and business acumen to the nonprofit sector, she then shifted focus and led several not-for-profit organizations through start-up and turnaround efforts before joining Mr. Fox to launch the Foundation in late 2000.
Ms. Brooks is a member of the Advisory Board for FasterCures Philanthropy Advisory Service and sits on the External Advisory Board for Emory University's Collaborative Center for Parkinson's Disease Environmental Research. Ms. Brooks serves on the Board of Overseers of the School of Social Policy and Practice at the University of Pennsylvania. She serves on the MBA Advisory Board of the Tuck School of Business at Dartmouth as well as the Advisory Board for Women in Business at Tuck. She is a past member of the National Advisory Environmental Health Sciences Council of the National Institutes of Health and director of the Parkinson's Action Network.
[back to top]
Gabrielle Campbell
Gabrielle Campbell is Assistant Vice President, Business Development at the Association of American Medical Colleges, where she manages the AAMC's intellectual property licensing and protection, business relationships and new business initiatives. She also serves on the Board of Directors for MedBiquitous, a medical education technology standards organization. Prior to joining AAMC, Gabrielle was a Licensing Officer at University of Washington's Digital Ventures technology transfer group, where she focused on patenting and licensing of software and digital content. Her studies include a BA in biology from the University of Pennsylvania and an MBA from the University of Washington, and she is working on an LLM through the University of Edinburgh in Innovation, Technology and the Law. Gabrielle was a Robert Bosch Foundation Fellow in Germany in 2000-2001.
[back to top]
Brian Casler
Mr. Casler joined the USPTO in 1992 after receiving a Bachelor of Science degree in Electrical Engineering from the Pennsylvania State University. In 1997 he was promoted to Primary Examiner reviewing applications involving medical diagnostic imaging. He is a Supervisory Patent Examiner (SPE) in Technology Center (TC) 3700, Art Unit(AU) 3737. As a SPE, he is responsible for ensuring his AU meets TC and Agency goals and is not only responsive to Agency initiatives, but also performs various special projects.
Currently as a SPE in AU 3737, Mr. Casler is responsible for applications drawn to medical diagnostic imaging, including magnetic resonance imaging (mri), nuclear imaging, X-Ray imaging, and ultrasound imaging.
[back to top]
Hector E. Chagoya C.
He is Manager of Technology Analysis & Transfer at Becerril, Coca & Becerril, S. C. , where he specialized since 1997 in several aspects of industrial property rights, including the analysis, drafting, prosecution and use of patents. He has been consultant in IP matters for Mexican and foreign companies in the fields of polymers, biotechnology, pharmaceuticals, chemical industry and electronics/communications, including trade secrets protection, patent strategies, patent litigation and licensing.
He is included in the 2005 and 2007 editions of the "Guide to the World's Leading Patent Law Practitioners" (Euromoney) and is co-author of the chapter for Mexico in the LESI publication "Licensing Best Practices: Strategic, Territorial, and Technology Issues". He is professor at La Salle University in the Chemical Engineering and has taught in diploma programs of intellectual property and technology transfer in several institutions in Mexico. He is currently president of the Mexico City chapter of the Mexican Institute of Chemical Engineers (IMIQ) and Treasurer of LES - México.
[back to top]
Fabrizio Conicella
Fabrizio Conicella has more than 10 years of experience managing R&D and technology transfer projects in ICT and Biotech fields. He worked for a research based company specialised in testing and for a territorial development agency for 6 years dealing with EU projects and territorial development projects with a strong focus on the support to the growth of local ICT initiatives. He also supported SMEs in solution of problems linked to the internationalization of activities and local clustering. From 1999 he is project manager at Bioindustry Park del Canavese Science Park coordinating all technology transfer activities and international networking and, from 2004, managing projects targeted to support the creation of innovative companies (Discovery project). In 2005 he became a Business Development Manager of all activities performed by Bioindustry Park. In 2000 he was also in charge of clustering activities at territorial level (Piemonte Bioscience initiative) and from 2005 was involved in the Transalpine Biocluster project. From 2006 he is project manager for Bioindustry Park of EU NetBioclue and PASSPORT projects. He is also member of CEBR (Council of European Bioregions). From 2005 to 2007 he was the National expert in Biotech and Life Sciences for InvestInItaly, the National Government Organization helping foreign companies set up or expand their business in Italy. Since January 2006 he has been the General manager of Bioindustry Park and vice president of KITE Association (www.iniziativakite.org). He is member of several working group at Regional, National and European level focused on Biotech, clustering, Incubation, technology transfer and Innovation.
[back to top]
Walter G. Copan
Dr. Walter G. Copan is Executive Vice President - North American Operations and Chief Technology Officer for Clean Diesel Technologies, Inc., Stamford, Connecticut, U.S.A. The focus of this role is bringing clean energy, energy efficiency and environmental technologies to global transportation and distributed power markets. He was previously Principal Licensing Executive at the National Renewable Energy Laboratory (NREL) of the U.S. Department of Energy. There his responsibilities included the licensing and commercialization of energy related technologies, new enterprise development, and partnerships with industry, academia and government.
Prior to joining NREL, Dr. Copan was Managing Director, Technology Transfer and Licensing for The Lubrizol Corporation, responsible for corporate venturing and new business development. Previous assignments in Dr. Copan's 28 year career with Lubrizol include leadership roles in research, product development, strategy, new ventures, business development and commercial management. He also headed Lubrizol Petroleum Chemicals Technology based in the U.K., with responsibility for product development, program management and technical service for Lubrizol's business in Europe, the Middle East, Africa and the Former Soviet Union.
He received his Ph.D. in Physical Chemistry from Case Western Reserve University, and his undergraduate degrees from CWRU are in chemistry and music. He has authored numerous professional publications and presentations, and serves on the boards of directors for several organizations. Dr. Copan has been an active member, committee chair, trustee, and officer of the Licensing Executives Society (LES) USA & Canada and LES International. He currently is LES Vice-President, U.S.A. Region, and within LESI is Chair of the Industry-University and Government Transactions committee. He also served as member of the National Advisory Council to the U.S. Federal Laboratory Consortium. Other professional associations include the Society of Automotive Engineers and the American Chemical Society.
[back to top]
Noel Courage
Noel Courage is a United States and Canadian patent agent with the intellectual property law firm Bereskin & Parr located in Toronto. He is also an Ontario lawyer. Noel's practice focuses on the patenting and licensing of chemical, biotechnological, pharmaceutical and mechanical inventions. He also provides opinions on patent validity and infringement. Another aspect of Noel's practice involves helping companies deal with drug and medical device regulatory issues.
[back to top]
Rick A. Daffron
Mr. Daffron brings more than two decades of software industry expertise to his role as President and CEO of Color Technology's Solution Group. Rick founded the company in 1990 and under his direction the company has brought workflow automation solutions to many Fortune 500 and Mid-Size Business Customers.
Mr. Daffron's continued vision for CTI's Software is to "Help our customers gain competitive advantage with solutions that enable more effective and efficient communications through Workflow Automation".
At Color Technology with the support of a Team of 20 plus programmers and creative employees they have developed a complete suite of automated workflow management products supporting Client's needs from Web Based Product Approval of the various stages of development, documentation of manufacturing compliance through Order Entry and Merchandising in the field.
Prior to Color Technology Rick spent 15 years in the Graphic Arts and Advertising Industry managing both the manufacturing and creative environments for several large companies. He is a past speaker at LES and other industry events and a Member of LES and LIMA.
[back to top]
Manisha A. Desai, Ph.D.
Manisha Desai is Regional Patent Counsel for Latin America at Eli Lilly and Company, a pharmaceutical company based in Indianapolis, Indiana. Since joining Lilly's patent division in 1999, Manisha has worked on the procurement and enforcement of patents worldwide. She also actively follows intellectual property issues relating to genetic resources and traditional knowledge various forums, including the Convention on Biological Diversity, and WIPO; and she co-chairs IPO's GR/TK committee.
[back to top]
Robert Dini
With a 35 year experience, Roberto Dini is one of the best known and appreciated experts in the field of Intellectual Property in Italy and Europe. He has been Head of the Patent and Trademark Office within the Indesit Group and is the inventor of 28 patents. In 1982, Mr. Dini founded Sisvel. This company soon became a leader in the licensing field, where it has established itself as one of the main international players by exploiting the value of its patents as well as those of third parties. He has been both CEO and President of Sisvel. Founder and Sole Director of Metroconsult, a Patent and Trademark Firm with offices in None Torinese, Milan and Genoa, where he actually assists clients in creating and exploiting their patent portfolio .
[back to top]
Eric M. Dobrusin
Eric M. Dobrusin gained admission to the State Bar of Michigan in 1988, and thereafter became registered to practice before the U. S. Patent and Trademark Office as a patent attorney. He graduated cum laude in 1985 from the University of Michigan (Ann Arbor, MI) College of Engineering with a B. S. E. in Materials and Metallurgical Engineering, and he graduated cum laude in 1988 from Wayne State University Law School (Detroit, MI).
With co-author Kathy White of Wayne State University Law School (and University of Michigan Regent), Mr. Dobrusin has published a book entitled: Intellectual Property Litigation - Pretrial Practice, (2nd ed. ,) Aspen Law & Business (1999), and is currently co-authoring a Third Edition of that book. He published the first edition in 1996. Mr. Dobrusin also has jointly authored a book scheduled to publish in Spring 2008, entitled "Intellectual Property Culture: Strategies to Foster Successful Patent and Trade Secret Practices in Everyday Business" (Oxford University Press).
In October 1999, Crain's Detroit Business Magazine selected Mr. Dobrusin as one of "40 Under 40" up and coming business people in Southeast Michigan. He was also selected for inclusion in the 2007 and 2008 editions of The Best Lawyers in America®, and was listed as a Michigan Super Lawyer in Fall, 2006 and Fall, 2007.
As a shareholder in a private law firm that he co-founded, Dobrusin & Thennisch PC, Mr. Dobrusin concentrates his practice in patent counseling and strategic patent prosecution mainly in the areas of materials science, biomedical devices, automotive technology, and semi-conductor device fabrication.
[back to top]
Carter Eltzroth
Carter Eltzroth is Legal Director of the DVB Project. DVB is the Geneva-based standards forum creating technical standards - implemented worldwide - for digital television. As a central participant within DVB since 1993, he leads its efforts in fostering voluntary licensing regimes of patents essential for DVB specifications. In addition to his work for DVB, he is involved in comparable projects with standards bodies located in the United States and China.
Carter Eltzroth has also served as Secretary General of the Association Européenne pour la Protection des Âuvres et services Cryptés (AEPOC) and as General Counsel of Nethold (FilmNet), the European pay television service. On behalf of the European Commission, he has conducted studies on conditional access and other "gateways" which may impede the launch and development of digital markets.
His recent publications include articles on the IPR policy of the DVB Project, including in JIT Standards & Standardization Research (summer 2008), Broadcasting and Development, Options for the World Bank (World Bank 2003) and Indian broadcasting, Technologies and Content Industries (GWU, forthcoming).
Carter Eltzroth obtained the French baccalauréat and is a graduate of Oxford University and Columbia Law School. A dual US-Belgian national, he is a member of the New York bar.
[back to top]
Masahiro Ezaki
Masahiro Ezaki joined, as of April 1, 2008, Toyota Technical Development Corporation ("TTDC"), a 100% subsidiary of Toyota Motor Corporation ("Toyota") and he is scheduled to be a Managing Director of TTDC coming June. Prior to joining TTDC, he led Intellectual Property Division of Toyota as a Senior General Manager. He worked for Toyota in the field of IP more than 30 years.
While working for Toyota, he served as a President of Japan Intellectual Property Association from 2002 through 2003 and a Visiting Professor of Intellectual Property for Graduate School of Kanazawa Institute of Technology for 3 years.
Within LESI, he has been a co-chair of Automotive Committee.
[back to top]
Jed Ferdinand
Jed is a Partner with Grimes & Battersby, LLP, located in Fairfield County, Connecticut and New York City. His practice includes all facets of intellectual property, licensing and entertainment law.
An accomplished trial attorney, he represents licensors, licensees, agents and inventors in all facets of intellectual property litigation. He also manages the worldwide trademark portfolios of famous brands and regularly negotiates merchandising and licensing agreements for a wide array of consumer products.
Jed is a member of the Board of three publications devoted to IP, The Licensing Journal, IP Litigator and Inventors Digest for Kids, and he writes the "Trademark Litigation" monthly column for the IP Litigator.
Jed was recognized by a leading IP publication as one of the top trademark attorneys nationally in 2004.
[back to top]
John A. Fraser
Mr. Fraser is currently Assistant Vice President for Research and Economic Development, and Executive Director of the Office of IP Development & Commercialization, Florida State University, Tallahassee, Florida (1996-present). Prior to that he served as Director, University/Industry Liaison Office at Simon Fraser University, Vancouver, Canada. Mr. Fraser brings substantial corporate and university experience to the FSU position. He has held positions as Executive Vice President and co-founder of UTC, Inc., a venture capital backed, North Carolina-based university licensing/technology transfer firm; President and CEO of UTI, a University of Calgary based for-profit technology transfer company; Vice President of TDC, Inc., a Toronto and Vancouver-based venture capital firm and President, Burnside Development, a technology commercialization consulting firm. He has co-founded three companies and assisted entrepreneurs launch another twelve technology based firms.
He is a member of the Board of Trustees of the technology transfer association AUTM, and served as the 2006 AUTM President; is a Founding Board Director of the Tallahassee region technology association, the TalTech Alliance and its Executive Committee; is a Founding member of Board of the Florida Research Consortium and its Executive Committee, appointed by the Governor to increase university/company interactions to better the Florida economy; is a Member of he Board of BioFlorida, the statewide bio/life sciences trade association. Mr. Fraser holds a Masters Degree in Biochemistry from the University of California - Berkeley.
[back to top]
Gary A. Gabrielsen
Gary is Vice President of Business Development at Astellas US LLC, the North American affiliate of Astellas Pharma Inc. Astellas is a global pharmaceutical company based in Tokyo that was formed by the merger of Fujisawa and Yamanouchi in April 2005. Gary joined the Deerfield, Illinois-based company in 2001, and is responsible for supporting the growth of Astellas' therapeutic area franchises in North America through strategic partnering initiatives.
Prior to joining his current employer, Gary spent 10 years with Abbott Laboratories, with positions in strategic marketing, business development, product management and pharmacoeconomics. He has earned an MBA from the University of Chicago as well as a BS in Pharmacy from the University of Illinois.
[back to top]
Paul Germeraad
Paul Germeraad is President of Intellectual Assets, Inc., a professional advisory services firm specializing in integrated business, R&D, and IP processes. Intellectual Assets, Inc. is distinguished by using cutting edge IP assessment tools and proprietary software, in addition to offering invaluable insight based on the depth and breadth of executive level management experience and industry coverage the firm's members represent.
Dr. Germeraad was previously Chief Operating Officer for Aurigin Systems, Inc. , a software start-up company, where he focused on the development of the company's intellectual asset management products for the Competitive Intelligence, Licensing and R&D communities. Prior to joining Aurigin in 1998, Paul worked for three Fortune 500 companies. He served as Vice President, Corporate Research for Avery Dennison, as the executive responsible for the Corporate Research Center. Before joining Avery Dennison, Paul was director of James River Corporation's Flexible Packaging Technical Center and held a variety of R&D and management positions at Raychem Corporation.
Paul is past Chairman of the Industrial Research Institute, an organization of Chief Technology Officers whose organizations account for over 70% of all US R&D spending. Paul joined the Licensing Executives Society (LES) Board of Trustees in 2002, served as Vice President, Education in 2004, and is chair of the LESI Long Range Planning Committee. He is an instructor for the LES Professional Development Series.
Paul is a graduate of the University of California, San Diego, with a B.A. in Chemistry. In addition, Paul holds a Ph.D. in Chemistry from the University of California, Irvine and an LL.B degree from La Salle Extension University.
[back to top]
James J. Greenberger
Jim Greenberger is a partner in the law firm of Reed Smith LLP and co-head of its worldwide Energy and Project Finance Group. Jim concentrates his law practice in representing emerging companies, project developers and private equity investors working with or investing in "cleantech" technologies.
Jim serves on the Executive Committee of the Illinois Wind Working Group and on the Advisory Board of the Renewable Energy Program at Illinois State University. He is a Vice President of the Chicago Chapter of the Association for Corporate Growth and co-chairs its Venture Network. Jim recently chaired the Midwest Alternative Energy Venture Forum, held at the University of Chicago Graduate School of Business in November 2007, and is chairing the upcoming ACG Advanced Automobile Battery Investment Summit to be held in Chicago on June 17, 2008.
Jim is a frequent speaker and author on topics relating to cleantech and private equity investing. His article,"Top Ten Legal Mistakes of Early-Stage Tech Companies", originally published in Business Law Today, is used in many business law course curricula. Jim is a former chair of the Commercial Finance & Transactions Committee of the Chicago Bar Association and a graduate of the University of Michigan Law School and Haverford College.
[back to top]
Robert R. Gruetzmacher
Dr. Gruetzmacher is the Director of Technology Commercialization in DuPont's Center for Collaborative Research and Education. During his career with DuPont, his responsibilities have included research, development, manufacturing, and marketing in the photopolymer imaging products and medical diagnostic businesses. He managed DuPont's infectious disease diagnostics research group in Boston, co-managed a food quality assurance business venture, and helped lead development of DuPont's technology transfer group and intellectual assets business.
In his current role in the Center for Collaborative Research and Education he manages the unrestricted grants program, helps lead DuPont's efforts to find appropriate university partners for sponsored and collaborative research, negotiates agreements and seeks new business opportunities with the academic setting, and advises company-wide on licensing-related matters. Most recently, he has been asked to take a lead in facilitating corporate-wide implementation of an "open innovation" R&D model.
Dr. Gruetzmacher holds a Ph.D. from Case Western Reserve University, and was the recipient of a National Institutes of Health Postdoctoral Fellowship. He has served as a trustee of the Licensing Executives Society and participates in several international forums dealing with topics such as university/company transactions, knowledge management, and the management and valuation of intellectual assets. He has authored publications and is invited frequently to gives talks on these topics. He is a member of the Licensing Executives Society, the American Chemical Society, the Association of University Technology Managers, and the American Association for the Advancement of Science. He is on the industrial advisory boards of the Larta Institute in Los Angeles and the Department of Macromolecular Science and Engineering at Case Western Reserve University.
[back to top]
Roger C. Hahn
Mr. Hahn is a patent attorney representing technology companies in biomedical inventions, chemicals, biotechnology and pharmaceuticals. Mr. Hahn is a frequent lecturer and writer on these and other intellectual property issues. His law degree is from the Chicago Kent College of Law. His B.S. in Bioengineering is from the University of Illinois at Chicago, and his M.S. in Biomedical Engineering is from The Johns Hopkins University. He currently serves as co-chair of the Biomedical Engineering Sub-sector of the Licensing Executives Society (LES).
[back to top]
Robert Harrison
Dr. Robert Harrison holds a B.A. (Hons) in physics from Oxford University and an M.Sc. in solid state Physics from Sheffield Uni- versity. He obtained his doctorate in electronic engineering from Sheffield University with a thesis on InAsPSb. He worked as an Examiner in the European Patent Office for two years before joining IBM's German Intellectual Property Department where he trained as a German and European Patent and Trade Mark Attorney. He was European IP Counsel for W.L.Gore & Associates from 1995 to 2001 and since then has been in a law firm.
Dr. Harrison specialises in working with companies funded by venture capital and private equity to maximise the value of their intellectual property. He has completed pre-investment freedom- to-operate studies and post-investment invention spotting re- views. He has established technology licensing programmes and brand name infringement enforcement strategies.
Dr. Harrison has a background in physics and electronic engineering and specialises in semiconductor physics, nanotechnology and bio-physics.
[back to top]
Robert Hart
Currently, Mr. Robert Hart serves as Chief Intellectual Property Counsel to
Harman International, a $4 billion in revenue audio systems company with
over 12,000 employees. In this role, he has global responsibilities for
Harman's patent, trademark, copyright portfolios including Harman's
3000+ patents and 3500+ trademarks worldwide; global intellectual property litigation; international transactional IP agreements; anticounterfeiting
investigations and white collar crime investigations. Robert
is also a member of Harman's Corporate Technology Council comprising
senior R&D leaders, charged with driving innovation and leading the
corporate R&D staff of the company.
Prior to his work at Harman, he was Division IP Counsel at Conexant
Systems, a major semiconductor manufacturer, where he was responsible
for the Wireless and Imaging Divisions. His career has allowed him to
enjoy a diverse general corporate practice that includes litigation,
intellectual property, transactional, employment and general corporate law. Robert Hart has technical backgrounds in electrical engineering, computer
science, chemistry and petroleum engineering. After working for several
years in the petroleum industry, he obtained his law degree from the
University of Tulsa and an LL.M. in Intellectual Property Law from The
John Marshall Law School. For the last eighteen years, he has worked both
in private practice and as in-house counsel.
Mr. Hart is a member of the American Corporate Counsel Association, the
Licensing Executives Society, the American Intellectual Property Law
Association, The Association of Media and Entertaining Counsel, Richard
the Linn American Inn of Court Customs, International Trade Bar
Association, and the Inter-Pacific Bar Association.
[back to top]
Tom Higgison
Tom is Technology Strategy Manager within the University of Edinburgh's commercial liaison company, Edinburgh Research and Innovation Limited (ERI). He joined ERI in August 1998 and over the last nine years has been active in developing and delivering technology transfer outcomes including licensing through the spinout route, and the securing of new funding for knowledge transfer initiatives.
He has responsibility for two areas of focus on behalf of the College of Science & Engineering: 1) licensing outcomes 2) strategic projects for funding support; and additionally across ERI, 3) implementing new and consistent commercialisation processes.
On graduating in Physics from the University of Strathclyde, Tom pursued a career in laser and optoelectronic engineering, and holds an MSc in lasers and optoelectronics from Heriot Watt University. He has worked across the full scale of company size and maturity, and in the process gained experience of a wide spectrum of business development activities, including the identification and assessment of commercially viable opportunities at an early stage, product definition, sales and marketing, and leading multi-disciplinary development teams in the translation of customer requirements into product.
At the University of Edinburgh he has expanded his experience of knowledge transfer, including as business development lead on licensing to a variety of University spinouts including MTEM, Spiral Gateway, Reactec, and Infogistics. His previous role for ERI as Business Manager involved managing a small team of specialists dealing with technologies in the areas of Physical Science and Engineering, including the identification, assessment and commercialisation of University technology, managing the commercial exploitation of early stage technologies including seed funding support mechanisms, and negotiation of commercial research and development contracts with industry and other funding agencies.
[back to top]
Steven M. Hoffberg
Steven M. Hoffberg is a patent attorney and partner in the firm of Milde & Hoffberg, LLP, White Plains, NY. Mr. Hoffberg has S.B. and S.M. degrees from MIT, MSEE from RPI, JD from Cardozo Law School, and attended U.Ct. Medical School. He specializes in complex patent prosecution, opinions, and IP strategies, transactions, and technology transfer and licensing in high tech, biotech, and other arts. Prior to becoming an attorney, he worked in engineering and engineering management. Mr. Hoffberg is an active inventor, named in 29 patents, in the fields of telematics, mobile ad hoc networking, game theory, multimedia signal processing and devices, human UI design, user preference profile based systems, cryotherapy, adaptive footwear, etc.
[back to top]
Dr. Bertram Huber
Dr. Huber started his professional career in 1978 at AEG-Telefunken AG. For eleven years he headed the Legal and Patents Department of ANT Nachrichtentechnik GmbH before joining Robert Bosch GmbH in 1995.
Since 2000, Dr. Huber has been responsible for the global Intellectual Property activities of the Bosch Group which rates among the major patent applicants worldwide. Dr. Huber is internationally active in a number of IP organizations and professional IP expert groups.
[back to top]
Bradley Hulbert
Bradley Hulbert has had substantial experience negotiating and drafting patent licenses over the past 30 years and is the current chair of the LES High Technology Sector. He is a founding partner of McDonnell Boehnen Hulbert & Berghoff, a 75-lawyer IP firm in Chicago, and is also an adjunct professor of law and the Director for Academic and Professional Program Development at the Chicago-Kent Law School.
[back to top]
Tetsushi Inada
Tetsushi Inada joined Kyowa Hakko Kogyo where he involved research works in Tokyo for 4 years and moved to US to establish new US pharmaceutical subsidiary focusing on Clinical Development and Business Development in NY & NJ for 15 years. In addition, he served as a president of New Your Pharma Forum, healthcare related organization consisting of about 100 members of Industries, Bio-industries and Government's offices of US, Japan and EU.
In 2005 he established Pharma-East Insight, Inc. in NJ and is now managing consulting
business mostly in US and Japan in the fields of Clinical and Business Development
strategy and executions for Healthcare and Pharmaceuticals. He is also serving as a
co-chair of Life Science Committee, at LESI since 2005 and as a board of directors for
Japan Pharma Licensing Association in Tokyo.
[back to top]
Guenter Isenbruck
Guenter Isenbruck is a chemist and a national German as well as a European Patent Attorney and has been with the Hoechst group from 1975 to 1996. He moved then into private practice, being since January 2003 senior partner of the patent attorney law firm Isenbruck - Boesl - Hoerschler - Wichmann - Huhn located in its Mannheim office, the majority of his activities being in chemical and pharma areas.
Mr.Isenbruck is immediate Past-president of LES Germany. He is specialized - besides global patent filing and prosecuting - in technology transfer, validity and FTO studies, and co-operations between industry and universities (including start-ups and spin-offs).
He obtained a diploma and a Ph.D. in Organic Chemistry from Johann Wolfgang Goethe University of Frankfurt and studied additionally Education at the university in Zuerich (Switzerland) and U.S Patent Law in 1979 at the Catholic University in Washington DC. Beginning 2007 he holds a Teaching Position at Robert Schuman University in Strasbourg on licensing practice and 2008 became chair of the Scientific Council of the IP center at the Mannheim University.
[back to top]
Mohan S. Iyer
Mr. Iyer's expertise is in representing innovative companies in transformative transactions, particularly strategic partnering and/or M&A. He brings a broad background in a range of functions including business development, strategic planning, marketing, product development, engineering and manufacturing. During his two years at Burrill & Company, he has advised both emerging and public biotech companies on strategic transactions in multiple therapeutic areas such as dermatology, ophthalmology, oncology, anti-virals and CNS. Mr. Iyer is also responsible for building Burrill & Company's India-based banking practice. Prior to joining Burrill, he was a member of the executive team at diaDexus, where he headed the marketing launch of a novel cardiovascular diagnostic product and also played a key role in two private financings totaling over $130mm. Previously, he was a healthcare consultant at The Wilkerson Group in New York and in San Francisco, assisting various biotech, diagnostics, and medtech companies with their market-based strategies. Mr. Iyer began his biotech career as a biochemical process engineer at Genentech, where he spent seven years, chiefly in large-scale GMP manufacturing of recombinant protein products. He holds a BS in Chemical Engineering, an MS in Biomedical Engineering, and an MBA.
[back to top]
Stephen Johnson
Stephen Johnson is the partner in charge of Kirkland's San Francisco intellectual property group. He is also a founding partner of both Kirkland's San Francisco and New York offices and the former head of Kirkland's New York intellectual property group. Mr. Johnson focuses his personal practice on domestic and international transactions. His practice draws on his many years experience working on a wide variety of transactions for both investors and corporate clients as well as his background in intellectual property. Mr. Johnson typically works in situations where intellectual property rights are crucial, where a client is entering into critical transactions with third parties such as outsourcing major functions or where a new transaction structure may be required. Mr. Johnson also works on novel transactions such as those involving the monetization of intellectual property.
Mr. Johnson delivers practical, business oriented advice in complicated technological and legal situations. According to Chambers USA, America's Leading Lawyers for Business 2007, one client said, "He's someone who can speak pragmatically and tell me what I really need to know about a matter."
Mr. Johnson's expertise has been widely recognized. He is listed in Euromoney's "Guide to World's Leading Patent Lawyers" and as a Northern California "Super Lawyer". As well as being recommended in Chambers USA: Leading Lawyers for Business, Mr. Johnson is also listed in the International Who's Who of Business Lawyers and the International Who's Who of Internet and e-Commerce Lawyers.
Mr. Johnson is a former senior chair of Technology Committee of the International Bar Association.
[back to top]
Nigel Jones
Nigel Jones is Co-Head of the Healthcare Sector Group, and a partner in the intellectual property department, of international law firm Linklaters LLP, based in its London office. He advises leading organisations in the healthcare, pharmaceutical and biotech sectors on intellectual property, regulatory and commercial matters. This includes assisting multinational pharmaceutical companies to co-ordinate international patent disputes; working with companies and investment banks on M&A and finance transactions; and identifying and implementing innovative ways for such organisations to make the most of their key commercial assets. He is an active member of a number of professional associations, including the Licensing Executives Society International (the UK chapter of which he is currently Vice-President), and a member of the editorial board of the Bio-Science Law Review.
[back to top]
Dr. Christian Kallinger
Christian Kallinger is team leader of the nanotechnology working group of the European Patent Office.
He graduated in physics from the Technical University of Munich and the University of Hawaii. His research focussed on scanning tunnelling probe microscopy on carbon nanotubes and later on nanostructured organic optoelectronic devices. After receiving his PhD from the Ludwig Maximilians University (LMU) in Munich he worked as Scientific Manager for the Center for NanoScience (CeNS) of the LMU Munich.
In 2000 he joined the German Patent and Trademark Office as patent examiner in the fields of Nanotechnology and Scanning Probe Microscopes. Since 2003 he is working for the EPO as patent examiner and classifier in the field of Measuring & Optics.
[back to top]
Richard D. Kelly
Richard D. Kelly is a partner in the firm's Litigation Practice Group and a member of the firm's Board of Directors. In addition to litigation, he actively counsels clients in all aspects of intellectual property matters. He has particular expertise in the impact of U.S. Food and Drug Administration regulations upon intellectual property rights. In addition to district court experience, he practices extensively before the International Trade Commission. He also has extensive patent prosecution and patent interference experience.
Mr. Kelly joined the firm in 1975 after receiving his Law degree from the Catholic University of America. He received his Bachelor of Science degree in Chemical Engineering from Northeastern University in 1970. Upon graduation, he joined the U.S. Patent and Trademark Office as an examiner.
Mr. Kelly is admitted to the Bar of Virginia and is licensed to practice before the U.S. Supreme Court, the Supreme Court of Virginia, the Court of Appeals for the Fourth and Federal Circuits, the U.S. Patent and Trademark Office, and numerous Federal district courts. He is a member of the American Intellectual Property Law Association (AIPLA), the American Bar Association (Patent, Trademark, and Copyright and Litigation Sections) and the International Trade Commission Trial Lawyers Association.
[back to top]
Dr. Rashid Khan
Dr Rashid Khan is currently assigned to King Abdullah University of Science & Technology (KAUST) with the responsibility in the areas of Intellectual Property, Economic Development & Research Programs. Rashid is defining the University R&D programs, and serving as the Champion for the Solar Energy Research Center.
Rashid has been a Consultant for Intellectual Assets & Technology Management of Saudi Aramco; he was instrumental for developing policies and procedures related to patent and copyright protection. Rashid was also instrumental for commercializing the first series of technologies for the Saudi Aramco.
Rashid Khan was the Distinguished Lecturer for the SPE for 2006-2007. He made presentations in various countries and many universities including Harvard and MIT. He served as a distinguished lecturer
Rashid served 13 years with Texaco and 5 years with the US Dept of Energy; Served as an Adjunct Professor for Vassar. Rashid briefly served as a technical advisor to the US White House and the United Nations Development Program (UNDP). Received many Innovation awards including Texaco's highest technical award for creativity and the American Chemical Society's Research Award. He 30 patent awards (granted or filed), published over 150 journal papers and has three Books on Energy & Environmental topics. His most recent book titled: Joy of Innovation & Business Development is now in press. He received his PhD & MS in Energy & Fuels Engineering from Penn State and MS in Environmental Engineering from Oregon State.
[back to top]
Jasbir (Jesse) S. Kindra
Jesse Kindra joined the National Institutes of Health, Office of Technology Transfer (OTT) in 2003. Prior to joining OTT, Mr. Kindra was Senior Corporate Counsel at a product development company where he specialized in preparing patent applications, licensing intellectual property, managing litigation and counseling corporate executives on intellectual property strategy. Mr. Kindra also worked in a law firm where he gained experience in patent prosecution and litigation. Mr. Kindra received a law degree (J.D. ) from Capital University Law School, an M.S. from Kellogg School of Management/Graduate School at Northwestern University, and a B.S. in Biology from the University of Illinois at Urbana-Champaign.
[back to top]
Sumiko Kobayashi
Sumiko Kobayashi is a Patent Attorney admitted to practice not only intellectual property prosecution but also intellectual property infringement litigation in Japan. She is a partner of the firm. She is active in the area of P prosecution and IP litigation in various fields including chemistry, biotechnology and semiconductor manufacturing equipment.
Mr. Kobayashi received her Bachelor of Engineering degree in Applied Chemistry from Saitama University in 1972. She worked as an examiner and trial/appeal examiner in the Japanese Patent Office for about 12 years. Between the Patent Office work and private work as a patent attorney, she traveled around the world for half a year. During the work as a patent attorney up to now she worked in a New York law firm for a year.
Ms. Kobayashi is a member of Japan Patent Attorneys Association (JPAA), LESI and LESJ, AIPPI, American Intellectual Property Law Association (AIPLA), Japanese Intellectual Property Arbitration Center (JIPAC) and Japan Association of Arbitration and ADR.
[back to top]
Stefan Koehler
Stefan has been working as a Licensing Associate for Epicentre Biotechnologies, a developer and manufacturer of molecular biology research reagents, for five years. Previously, he taught business classes at the University of Munich Entrepreneurship Center as well as the University of Wisconsin Business School and worked for KPMG as a consultant.
[back to top]
James Kovach, MD, JD
Dr. James Kovach became President and COO of the Buck Institute for Age
Research in July 2005. Prior to his appointment, Kovach was Executive Vice
President and COO of Athersys, Inc. , a public biotechnology company based in
Cleveland, Ohio. He has also directed the Office of Technology Management at
the Case Western Reserve University School of Medicine in Cleveland.
Dr. Kovach also spent seven years as a middle linebacker in the National Football
League while earning his medical degree from the University of Kentucky during
consecutive off seasons.
After retiring from the NFL, Kovach obtained his law degree from Stanford
University and joined the law firm of Cooley Godward, LLC. His professional
interests have focused on the interface between academic medicine and the
commercial marketplace. He has previously served as Chair of the Biotechnology
Industry Organization (BIO) subcommittee on Technology Transfer and currently
serves as the Buck Institute's institutional representative to the California Institute
of Regenerative Medicine.
[back to top]
V. Lakshmi Kumaran
Qualifications
LL.B. (Law), University of Madras
M.Sc. Mathematics, University of Madras
Professional experience
Mr. Lakshmi Kumaran is the founding and managing partner of the Law Firm "LAKSHMIKUMARAN & SRIDHARAN". The firm was founded in 1985 and has offices in New Delhi, Mumbai, Bangalore, Chennai, Hyderabad and Ahmedabad. The areas of specializations of the firm are intellectual property, tax, international trade and corporate laws.
Intellectual Property:
Mr. V. Lakshmi Kumaran has practiced as a Litigator in the area of Intellectual Property and, in particular, in the area of patents. Mr. Lakshmi Kumaran has handled several high profile litigations.
His Law Firm handles:
- Patent drafting
- Prosecution before the Controller of Patents & Trade Mark
- Pre-grant and post-grant opposition
- Litigation
His clients include many well known Fortune-500 Companies and big Indian Corporates.
He began his career as Assistant Professor in Mathematics at Madras University.
He served as Indian Revenue Service Officer for over 10 years with Government of India, before starting his legal practice in 1985.
Professional memberships
Member, Supreme Court Bar Association
Member, Licensing Executive Society
Member, International Bar Association.
Member, International Association for Protection of Intellectual Property, Member, Asian Patent Attorney Association
[back to top]
Christine Lebrón-Dykeman
Christine received her bachelor's degree from Smith College. She graduated from the University of Iowa College of Law with honors in 1996, and served as a law clerk to the Honorable Robert W. Pratt, U.S. District Court for the Southern District of Iowa.
Christine joined McKee, Voorhees & Sease in 2002 where her practice focuses primarily on trademark prosecution, intellectual property litigation and licensing. Christine is actively involved in the International Trademark Association (INTA), serving on the Madrid Protocol Subcommittee and gives frequent presentations to business groups such as the Licensing Executive Society (LES). Christine heads the firm's Trademerk Practice Group.
[back to top]
Lee Chun
Lee Chun has been the initial partner of Grandall Legal Group, which is a large-scale legal firm of some standing in China and sets its offices respectively located in nine cities such as Beijing, Shanghai, Shenzhen and Hong Kong with aggregate sum of 116 partners and more than 800 practicing lawyers.
Lee Chun is now undertaking the positions of president of Lawyers Development Strategy Committee of All-China Lawyers' Association and director of Shenzhen Lawyers' Association. As an excellent and senior commerce lawyer with over 27 years' practicing, he has considerable accomplishments and influences in the areas of the company's restructuring, listing of securities, investment and financing, etc. His customers are ranging from large-scale State-owned enterprises to private enterprises, most of which are publicly listed companies. 52 years old as he is this year, Lee chun is very fond of outdoor sports, particular the self-driving tours.
[back to top]
Tyler Lenane
Tyler Lenane is Corporate Counsel for RealNetworks, where he provides business and legal counsel in connection with the music licensing for all of RealNetworks' services. In addition, he is responsible for the licensing of Real's intellectual property for use with home and mobile devices.
Before joining RealNetworks, Lenane spent three years as an associate at Jenkens Gilchrist Parker Chapin LLP in New York City and one year as an associate at Troutman Sanders LLP in New York City. As an associate, he represented clients in commercial litigation and intellectual property and entertainment law. He also represented a number of artists, in recording agreements, film option agreements, and licensing and sub-licensing agreements.
Lenane received his JD in 2002 from Benjamin N. Cardozo School where graduated Cum Laude. He is admitted to practice in New York State and the U.S. District Courts for the Southern and Eastern Districts of New York.
[back to top]
Anita Leung
Anita specializes in the protection, exploitation, and enforcement of intellectual property rights, with particular focus on commercial IP work relating to licensing, franchising, manufacturing, distribution, advertising, sponsorship; transactional support, IP audit and due diligence. She also handles and advises on Hong Kong IP enforcement and litigation; product registration, labeling and regulatory issues.
Anita is the current Chair of the Legal Committee of the Licensing Executive Society China Hong Kong Sub-Chapter. She also sits on various other committees, including the Law Society IP Committee and the Copyright Committee of the Asian Patent Attorneys Association Hong Kong Chapter. She is a member of the Board of Governors of the American Chamber of Commerce and a Council Member of the Federation of Women Lawyers.
[back to top]
Russell E. Levine, P.C.
Russell Levine currently serves as an International Delegate to the Licensing Executives Society International ("LESI") organization and as Chair of the LESI Patent and Technology Licensing Committee. He also is Program Co-Chair for the LESI 2008 Annual Meeting. He is a past chairman of the LES (USA & Canada) Litigation Committee and past chair of the LES (USA & Canada) Laws and Government Action Committee. Recent LES workshops in which Russell participated include "Experimental Use Rights," at the LESI annual meeting in Zurich; "Top 10 Changes in Patent Litigation Affecting Licensing," at the LES (USA & Canada) Spring meeting in Atlanta; "Top 10 Things You Need to Know About U.S. Patent Litigation," at the LES ANZ annual meeting in Australia; and "Top 10 Court Decisions of 2006 Affecting Licensing," at the LES (USA & Canada) annual meeting in New York. He is a member of the ABA, the AIPLA, the Federal Circuit Bar Association, the International Bar Association, the International Trade Commission Trial Lawyers Association and past chairman of the Young Lawyers Committee of the AIPLA.
Russell has been active throughout his career in civic, charitable and industry organizations. He currently is Vice-Chair and Chair-Elect of the President's Council of Chicago's Museum of Science and Industry and Co-Chair of its Membership Committee. He also serves on the Editorial Board of the "Managing Intellectual Property" monthly publication. For the past 16 years, Russell has taught a course for the Society of Automotive Engineers entitled "Patent Law for Engineers."
Russell was recently invited to become a Master in the Richard Linn American Inn of Court. He also was recently inducted into the International Directly of Distinguished Leadership Hall of Fame for his contributions to the field of Intellectual Property. He also for several years running has been recommended by his peers in a statewide survey by the Leading Lawyers Network to be among the Top Lawyers in Illinois in Intellectual Property.
He holds a B.S. in Interdisciplinary Engineering and a B.S. in Economics, both degrees from the University of Michigan. He received a law degree from the University of Chicago, and he is registered to practice before the United States Patent and Trademark Office. He is admitted to the bars of Illinois, New York, District of Columbia, the U.S. Supreme Court, the Federal, 1st, 2nd, 3rd, 4th, 5th, 6th, 7th and 11th Circuits, the Northern District of Illinois, the Eastern District of Wisconsin and the Eastern District of Michigan.
[back to top]
Aron Levko
Aron Levko is a partner in PricewaterhouseCoopers' Chicago office and is a leader in the Intellectual Asset Management Practice in the Americas. He has extensive experience working with trial lawyers, corporate management, and entrepreneurs in a broad range of industries for more than 35 years. Mr. Levko's current work focuses on intellectual asset matters, as well as other complex business valuation analysis. He has extensive expert testimony experience on issues such as damages analysis, licensing practices, business valuations and commercial success. He has prior experience at Ford Motor Company as a car product planner and Rockwell International as a plant controller. Mr. Levko has an MBA in Finance from the University of Chicago and a BSE in Industrial & Operational Engineering from the University of Michigan. He is an Accredited Senior Appraiser, Certified Management Consultant and a Certified Production & Inventory Control Manager. Mr. Levko is also a candidate as a Certified Licensing Professional.
[back to top]
Kening Li
License(s): California, Wisconsin, District of Columbia; United States District Court for the Southern District of California
United States Patent and Trademark Office.
Education and Honours:
University of Wisconsin Law School, J.D. , 1998, with honours; University of Wisconsin-Madison, Ph.D. Plant Pathology, 1995; Nanjing University, China, B.S. , Biology; CALI Award for the Excellence in Copyright Law, 1997; John Lawton Award for Excellence in Community Service, 1998; DuPont Qualicon Excellence of Service Award, 2001
Professional Background: Associate, Foley & Lardner; Senior Counsel, E. I. Dupont de Nemours & Co. ; Counsel, Crowell & Moring LLP; Shareholder, Baker Donelson Bearman Caldwell & Berkowitz PC; Senior Consultant, Pinsent Masons LLP (Shanghai)
Significant Professional Experience: Dr. Kening Li, leads the Intellectual Property team of Pinsent Masons LLP in the Asia Pacific region. He focuses his practice on intellectual property law. He has assisted clients, ranging from start-up to Fortune 500 companies, in managing intellectual property assets as an integral part of their comprehensive competition strategy. He is experienced in formulating overall intellectual property strategy, resolving difficult freedom-to-operate obstacles, negotiating licensing agreements, and effectively utilizing existing intellectual property portfolio to strengthen client's competitive positions. Dr. Li has substantial experience drafting and prosecuting biotechnology, chemical and pharmaceutical patents. He has participated in complex commercial and patent litigations, including proceedings before the U.S. International Trade Commission (ITC). Notably, he conducted the IP due diligence analysis for a German client in its acquisition of a California biotech company, and an Indian company in its acquisition of a major biotech company in Maryland, and helped a Maryland biopharmaceutical company in its due diligence analysis and license negotiations for a major portfolio of small molecule lead compounds.
Public Service/Community Affairs: General Counsel, Chinese Bio-Pharmaceutical Association, USA; Pro bono counsel, Montgomery County, Maryland, Public Defender's Office.
[back to top]
Jeremy Lowe
Jeremy Lowe is a partner at Axinn, Veltrop & Harkrider, LLP. Throughout his career, Jeremy has conducted numerous high-stakes patent litigations. Jeremy also serves clients in the area of portfolio acquisition, enforcement, valuation and licensing strategies. He developed the concept of a "patent playbook" as part of a patent business plan that attempts to drive maximum value from patent assets. He has spoken on these topics throughout the U.S.
Jeremy has been active throughout his career in numerous professional associations. He is also a member of AIPLA, IPO, LES, AIChE, and the Washington University School of Law Intellectual Property Law Advisory Board.
[back to top]
Terry Ludlow
Terry Ludlow founded Chipworks in 1992 to offer semiconductor and microelectronics system reverse engineering services to companies wanting to build their competitive advantage, and protect and grow the potential of their intellectual property. He is currently Chipworks' Chairman, CEO and the Company's major shareholder.
Chipworks began as a one person company and today is a high performance team of international technology experts and patent licensing professionals. Under Terry's leadership Chipworks has grown to more than 125 employees with a world wide customer base that recognizes Chipworks as an innovative technical services company that provides high value technology knowledge. Headquartered in Ottawa, Chipworks has offices in Korea, Japan, Poland and Taiwan, with representation in Israel and other semiconductor and microelectronics technology centres.
Terry is a frequently sought out speaker (LES, Corporate Patent Congress, The Wall Street Transcript, Information and Technology Association of Canada) and publisher of several technical and IP focused articles, with over 25 years experience in the industry.
[back to top]
Ken Macleod
Dr. Macleod joined Paul Capital Partners in 2004 and is responsible for sourcing and evaluating investment opportunities outside North America. Based in London, U.K., Dr. Macleod has a strong operational background in the pharmaceutical industry having previously held senior management positions over a 15-year career at Serono, Abbott Laboratories and Beecham Pharmaceuticals. More recently Dr Macleod was a Venture Partner at Schroder Ventures Life Sciences where he was responsible for deal sourcing, evaluation and negotiation of pharmaceutical investment opportunities. Dr. Macleod earned his Ph.D. from the University of York, U.K. and his B.Sc. in Biology from the University of Manchester, U.K. He is on the Board of Supervisory Directors of the Dutch biotechnology company Pharming.
[back to top]
Joe Mahoney
Joe Mahoney concentrates on intellectual property law. He has served as lead counsel and co-counsel in patent, trademark, trade dress, and trade secret litigation. His training in pharmacy (Doctor of Pharmacy) gives him a unique understanding of scientific and technical issues, bolstering his extensive legal experience. Legal 500 has recommended him for Patent Litigation - Life Sciences/Chemical. His experience includes representing innovator drug companies in Hatch-Waxman Act patent litigation; rendering opinions relating to the infringement, validity, and enforceability of patents; and negotiating and drafting patent licenses, co-marketing, and joint venture agreements for a variety of products. In addition, Joe leads IP due diligence assessments relating to acquisitions and mergers involving complex patent portfolios and pending litigation, including extensive document reviews and inventor and witness interviews.
[back to top]
James E. Malackowski
James E. Malackowski is the President and Chief Executive Officer of Ocean Tomo, LLC, an integrated Intellectual Capital Merchant Banc® firm providing valuation, investment and risk management, corporate finance and expert services. Ocean Tomo assists clients - corporations, law firms, governments and institutional investors - in realizing Intellectual Capital Equity® value broadly defined. Subsidiaries of Ocean Tomo include: Ocean Tomo Auctions, LLC; Ocean Tomo Asset Management, LLC; and Ocean Tomo Capital, LLC -- publisher of the Ocean Tomo 300® Patent Index (Amex: OTPAT), the Ocean Tomo 300® Patent Growth Index (Amex: OTPATG) and the Ocean Tomo 300® Patent Value Index (Amex: OTPATV).
Mr. Malackowski is an internationally recognized leader in the field of Intellectual Property ("IP") management as well as a noted expert in business valuation and intellectual property strategy. He is a member of the IP Hall of Fame Academy and was recognized in 2007 as one of the fifty most influential people in intellectual property. Prior to forming Ocean Tomo, he served as a finance and investment advisor working with one of the Nation's oldest investment banks as well as one of Chicago's largest private equity firms. Mr. Malackowski began his career spending fifteen years as a management consultant and forensic accountant focused on intangible assets. In this capacity Mr. Malackowski served numerous roles as a founding principal including President and Chief Executive Officer of his firm, growing the practice to the nation's largest before its sale.
Mr. Malackowski has advised clients and counsel on business valuation issues as well as all phases of the technology transfer process. He has substantial experience as a Board Director for leading technology corporations as well as companies with critical brand management issues. Mr. Malackowski's expertise extends to intangible asset portfolios as well as business segments and complete entities. He has a unique appreciation for the hidden intellectual capital within emerging markets.
Apart from his own firm, Mr. Malackowski has served in a leadership role with numerous corporate entities, both public and private. He is a member of the President's Council for the Chicago Museum of Science and Industry and a current Director of Invent Now, Inc. , a subsidiary of the National Inventors Hall of Fame where Mr. Malackowski previously served as Trustee. Mr. Malackowski is Chair of the Membership Committee and Secretary for The Licensing Executives Society International, Inc. He is a Past President of The Licensing Executives Society USA and Canada, Inc. and a former Director of the International Intellectual Property Institute as well as a prior Resident Advisor for the U.S. Department of Commerce and U.S. Information Agency on matters relating to intellectual capital.
On more than thirty occasions, Mr. Malackowski has served as an expert in Federal Court on questions relating to intellectual property economics, including the subject of business valuation and the impact of advertising programs. As an inventor, Mr. Malackowski has nine issued U.S. patents and an even larger number of pending applications. He is an Adjunct Instructor at the University of Notre Dame Mendoza College of Business where he was a Summa Cum Laude graduate majoring in accountancy and philosophy. Mr. Malackowski is a Certified Licensing Professional and a Registered Certified Public Accountant in the State of Illinois.
[back to top]
Marty Malysz
Marty Malysz has 19 years of experience providing automated licensing and royalty systems to owners and licensees of intellectual property. In January 2005, Mr. Malysz founded Dependable Solutions, Inc. , to offer the latest web-based solutions to trademark licensors and licensees in the consumer product, entertainment and apparel industries. At Dependable Solutions, Inc. , Mr. Malysz manages a ten-person team of experienced analysts, programmers and marketing personnel from the Los Angeles headquarters location. He continues to sell, consult and implement licensing financial management solutions at trademark to licensors and licensees and promote all automated licensing financial management solution vendors. Mr. Malysz is a past speaker at LES, LIMA and other licensing industry events. At LES Spring 2008 conference, he will lead the panel discussion on "Choosing a Licensing Automation Vendor" on Monday May 5th
[back to top]
Robert Matlin
Robert Matlin is a District Vice President with the American Arbitration Association. In addition to his management responsibilities at the AAA, he conducts presentations for public and private sector audiences on a variety of ADR-related topics and assists businesses with the design of ADR programs. He also serves as an Adjunct Professor of Law, teaching a course in mediation at the De Paul University School of Law. A graduate of the University of Illinois at Urbana-Champaign and Boston University School of Law, Mr. Matlin practiced for a number of years as a Director and Senior Counsel in the Corporate Law Department - Litigation Division of the CNA Insurance Companies where he supervised a wide range of commercial litigation. Mr. Matlin is currently Co-Chair of the Chicago Bar Association Alternative Dispute Resolution Committee and is a certified mediator with the Circuit Court of Cook County and Center for Conflict Resolution. Mr. Matlin's recent article, "Alternative Dispute Resolution and Its Use In Commercial Insurance Disputes", appears in the June 2006 edition of the Metropolitan Corporate Counsel.
[back to top]
James A. McCarthy
Jim McCarthy is Senior Vice-President, Corporate Development, for Expression Genetics, Inc. , a biopharmaceutical company that specializes in the delivery of therapeutic nucleic acids for cancer, cardiovascular, orthopaedic and other diseases. His background includes a twenty five year career with Bristol-Myers Squibb and Eli Lilly & Company. He has spent over a dozen years in corporate business development and licensing roles with pharmaceutical, medical device and ethical nutrition businesses. These efforts included projects in over 30 countries and resulted in over 50 completed agreements across a range of external growth alliance transactions (i.e. acquisitions, licensing, research agreements etc. ) valued in excess of $700 million. He has held positions in international business development, strategic studies, product marketing, marketing research and patient care across a variety of technologies, therapeutic categories and products. His experience includes pharmaceutical marketing positions involving the start up of strategic therapeutic business units, new product introductions and life cycle management of established products in oncology, central nervous system and cardiovascular fields, and in the cardiac device market.
In addition he has held positions in corporate development with PharmaVentures, a global strategic transaction advisory firm, specializing in deals and alliances, Technology Innovations, LLC, a portfolio research and development corporation, and the Arthur Young Health Care Consulting Group. Jim has conducted professional presentations on international business development, licensing and technology commercialization both in the U.S. and abroad.
Jim holds an MBA in finance from Indiana University and B.S. degree in Physical Therapy from State University of New York Upstate Medical Center Syracuse.
He has been a long term member of the Licensing Executive Society (LES) and served as committee Chairperson to pioneer the "2007 BioPharmaceutical Royalty Rate and Deal Terms Survey".
[back to top]
John T. McEntire
John T. McEntire has spent eighteen years in marketing, business development and licensing of patents, copyrights and trademarks. The past 12 years he has led the software and copyright group at the University of Illinois through technology commercialization with focus on economic development via new company formation and license execution. He has experience developing and implementing strategic plans for businesses and technology transfer organizations in the U.S. and Japan. Prior to his work in university technology transfer, he spent six years doing business in the Pacific Rim including software and medical laser distribution. Five years of that he was a partner in a boutique consulting firm in Tokyo representing and setting up operations for Macrovision, Franklin-Covey, Michael Graves - Architect and Sam Snead Golf Course Design and over 50 independent movie producers. He is a frequent presenter at AUTM, LES, Law Seminars International and the Japanese Patent Office.
[back to top]
Daniel M. McGavock
Dan McGavock is a Vice President and IP practice leader of CRA International (NASDAQ: CRAI), a business, financial, and economics consulting firm with over 28 worldwide locations spanning 10 countries and 4 continents. CRA's IP practice provides valuation, litigation support/expert testimony, transaction advisory, cross-border transfer pricing, and strategic consulting services related to all types of IP and intangible assets. Dan has specialized in the valuation and strategic management of IP for over 22 years. He has valued IP in a broad array of strategic, regulatory, and transactional contexts and has provided expert testimony on IP damages issues on over 50 occasions. Prior to CRA's acquisition of InteCap in 2004, Mr. McGavock served as InteCap's President and as a member of its Board of Directors. He is also a registered CPA and currently serves as Vice Chairman of LESI's audit committee.
[back to top]
Todd Melioris
Todd has over 17 years experience in selling, implementing and building third party relationships for the top ERP organizations in the world, as well as extensive experience with mission critical applications for many of the top fortune 100 enterprises. Todd's services career began with implementation of a
global Accounting and Royalty Management System for TechData. More recently, Todd has served as President and CEO of National Summit Group, a national residential and commercial building company specializing in private labeling third party goods and services serving as a Licensee for over 900 Licensors. Previously, Todd worked as Vice President, Market Development & Integration, at McKesson Corporation, a healthcare information technology and supply company. One of Todd's main focuses at McKesson was evaluating, selecting and rolling out a Corporate-Wide Royalty/Patent Management Solution. Prior to his position at McKesson Corporation, Todd was Vice President, Global Alliances, at Datastream Systems where his focus was on third party revenue along with Mergers and Acquisitions. Earlier, Todd co-founded and took public Client Server Solutions, Inc. , a global business consulting firm that focused on mission-critical software implementations of SAP, Oracle, PeopleSoft, Epicor and Great Plains. Currently, he holds a gratis position as President and CEO of the National Healthcare Council, an industry support organization partnered with Harvard University that builds leadership programs for Fortune's top healthcare CEO's nationwide. Todd holds a bachelor's degree in Mathematics from the State University of New York, and a master's degree in Mathematics, concentrated in computer science, from Georgia State University. In 1998 Todd, who is active in professional and civic organizations, was named "Alumnus of the Year" by Georgia State University.
[back to top]
Don Merino
Don Merino is general manager, intellectual property, at Intellectual Ventures where he focuses on a variety of projects relating to intellectual property and invention.
Prior to joining Intellectual Ventures, Dr. Merino spent 4 years at Intel Corporation where he was director, strategic business development. In this position, Dr. Merino was responsible for managing the Intel licensing program.
Prior to his work at Intel Dr. Merino was director of licensing for General Instrument. He received his B.S. from the US Naval Academy in 1984 and his M.E.M.E and Ph.D. from Stevens Institute of Technology.
[back to top]
Cyrus K. Mirsaidi
Mr. Mirsaidi brings to AltheaDx more than 15 years of senior management experience in strategic planning, business development, sales and marketing. With key sales and marketing roles at Nichols Institute Diagnostics (division of Quest Diagnostics), his accomplishments included negotiation and implementation of several international distribution agreements, global task force leadership, and development of new strategies for application of routine 'immunoassay kits' to more profitable 'Point of Care' markets. Since Quest Diagnostics, he has been a contributor to several small biotech and pharmaceutical drug discovery companies that included his role as Executive Director and General Manager of Ontogen Discovery Systems with full operational and P&L responsibilities. Joining Althea Technologies, Inc. in 2006, his expanding business development and operational roles resulted in the strategic evaluation and re-positioning of the company's exclusive I.P. in multiplex PCR from its pre-clinical focus to a spin-out in clinical diagnostics.
Mr. Mirsaidi received a B.S. in Biology from the University of California, Irvine. He currently resides in San Diego.
[back to top]
Tanya Kaptsan Moore
Tanya Kaptsan Moore is a General Manager of Outbound IP Licensing in Microsoft's corporate Intellectual Property & Licensing group. Her responsibilities include formulating outbound technology licensing strategies, identifying and negotiating licensing arrangements in various Microsoft technology areas, including financial valuations, and leading a team of licensing executives. In her IP career, she has led and participated in a wide variety of transactions involving the licensing of patents, know-how, copyrighted materials, and trademarks, as well as asset sales, divestitures and joint ventures.
Prior to assuming her position with Microsoft, Ms. Moore was a key member of IBM's Intellectual Property & Licensing organization. Ms. Moore joined IBM in 1980 and spent the early part of her career in software development for a number of IBM's operating systems. She has held numerous technical positions, including project and quality management, where she received many awards. During this time, she also served as an adjunct instructor at IBM's Software Quality Institute. She has held a number of technical management positions in applications and systems software product development, transitioning in the mid-nineties to the business side of IBM, initially in server group OEM sales and later joining the IBM corporate IP group. In late 2003, Ms. Moore left IBM to join the Microsoft IP team.
[back to top]
Anita Nador
Anita Nador is a partner with McCarthy Tetrault LLP. Ms. Nador advises life sciences companies in all aspects of strategic intellectual property and commercialization planning and portfolio management including regulatory approval, litigation, license agreements, and other intellectual property-related transactions. Ms. Nador is actively involved in several professional organizations. She is currently a Director of the Toronto Biotechnology Initiative (TBI) and is past co-chair of the Toronto Chapter of the Licensing Executives Society. She regularly speaks and writes on topics related to intellectual property and technology transfer issues. She was on the editorial board of Transpharma, an international technology transfer publication for the health and biosciences and is a guest lecturer in Health Law in the department of Health Policy Management and Evaluation at the University of Toronto. Prior to her career in law, Ms. Nador conducted research at Brigham and Women's Hospital/Harvard Medical School in Boston, Massachusetts, and at Allelix Biopharmaceuticals in Mississauga, Ontario. Ms. Nador received her BA in Molecular Biophysics and Biochemistry from Yale University and her LLB from the University of Toronto. She was called to the Ontario bar in 1995. Ms. Nador is a registered patent agent in Canada and the United States, and a registered Canadian trade-mark agent.
[back to top]
Jack Nightingale
Jack Nightingale has 23 years of business development, product development, strategic planning, executive management, and management consulting experience. He led global business development activities for a $3 billion division of Honeywell for 5 years. As President of a biotechnology company, he was responsible for licensing research technologies and intellectual property to major pharmaceutical and biotechnology companies. Most recently, he has served as a management consultant on business development to leading global pharmaceutical, biotechnology, medical diagnostics, and consumer healthcare companies. Mr. Nightingale received a Bachelor of Arts degree from Harvard University and an M.P.A. in Economics and Public Policy from Princeton University.
[back to top]
Julian Nolan
Julian Nolan is based in Switzerland and is involved in setting up a new Intellectual Property business.
Most recently Julian has served as the European Vice President of Licensing for Honeywell, where his team created and managed the licensing business which spans all of Honeywell's operations in the aerospace, automotive, speciality materials and control systems industries.
Julian contributes a column to the BBC on licensing and Intellectual Property management and is a graduate of both Cambridge University and the University of Essex.
[back to top]
Wallace L. Oliver
Wallace L. Oliver is an intellectual property legal consultant and is engaged primarily in worldwide chemical technology intellectual property protection and use.
He received his J.D. degree cum laude from Northwestern University School of Law and a B.S. in Chemistry from the California Institute of Technology and a Ph.D from Northwestern University in physical organic chemistry. He is admitted to the Illinois Bar and is registered to practice before the USPTO.
He joined the Patents and Licensing Department of Standard Oil Company (Indiana) and became General Patent Attorney for Amoco Corporation (subsequently BP Amoco Corporation) with responsibilities for managing patent functions for a significant portion of the chemical business area. During his 29 years at that company, he acquired substantial experience in worldwide licensing of chemical and polymers technology. International licensing experience includes activities in Western and Eastern Europe, Japan, China, Taiwan, and South Africa. He was Of Counsel to Welsh & Katz, Ltd. from 2003 through 2007.
[back to top]
Dwight C. Olson
Dwight C. Olson is a Certified Licensing Professional, a Sr. IP Advisor to CONSOR, Principal at Intellectual Assets, and Founder of V3Data. Dwight was Executive Vice
President of TAEUS International, a Vice President at Iron Mountain and was founder of
Data Securities International (DSI) acquired by Iron Mountain Inc. the world's largest
record management company in 1997. Mr. Olson has over 40 years of experience in the
computer software industry. He began his career in the research and development of
supercomputers, parallel processing systems and related application architectures in the
60's and 70's.
Mr. Olson is called the "father of technology escrow" and often speaks on the topic of
using technology escrow as a business tool, valuation of software, trusted third parties in
electronic commerce applications on the Internet, and about securities firms using only
electronic records. He has been involved in the start-up of several software companies as
well as serves on the board of several companies.
Mr. Olson is a former President of the Licensing Executives Society (LES), USA and
Canada, with his wife Lois Chaired the 2003 LES San Diego Annual Meeting and he has
served as chair of LES and LESI information technology and Internet committees. He
was an associate member of the American Bar Association's Electronic Commerce Law
and Information Security Committee working on the ABA's Digital Signature
Guidelines.
[back to top]
Alan Paau, MBA, PhD
Dr. Paau is responsible for the strategic management of all technologies and intellectual property that arise from the research activities at Cornell University - both at the Weill Medical College in New York City and at the general campus in Ithaca. Prior to joining Cornell in January 2007, Dr. Paau for nine years was Director and Assistant Vice Chancellor for Technology Transfer & Intellectual Property Services at the University of California, San Diego (San Diego, CA). From 1994 to 1998, he was Executive Director of the Iowa State University Research Foundation, Inc. and Director of Intellectual Property & Technology Transfer at Iowa State University (Ames, IA). Until 1994, he was Associate Director of the Biotechnology Center at the Ohio State University (Columbus, OH) with responsibilities in research, teaching, research administration, technology management, and industry liaison.
Before returning to the academic environment in 1992, Dr. Paau held various research and management positions of increasing responsibilities in the Cetus Corporation and the W.R. Grace & Co. organizations for 12 years and led the development of two commercial products.
Dr. Paau holds a Ph.D. degree in Biological Sciences and a Master of Business Administration degree. He also attended briefly the Drake University School of Law.
Dr. Paau currently serves on the Boards of Directors of Bridgetech Holdings International, Inc., Vivo Development, Inc., API Development, Inc., and NanoBioNexus. He also serves on the Boards of Advisors of Mushroom Networks, Inc. and University Inventions, Inc.
[back to top]
Jack T. Peregrim
Jack has 30 years business and consulting experience in new business development, corporate growth, P&L management, new business start-ups and strategic and business planning. He has pioneered the Voice-of-Market™ process that has radically changed the approach of many major and successful Fortune 100 organizations and his firm has employed this process in hundreds of client engagements.
In his consulting career since 1989, he has worked with over 400 of these corporate clients. These assignments have contributed several billion dollars in value to these clients in the forms of new products, applications for technologies and other assets, acquisitions, optimized development portfolios, new value chain strategies, and expansion into new markets. The clients served are primarily major corporations in North America, Europe, and Asia but they also include new venture start-ups. He is the President of PARAGON Development.
He is a long time active member in several new business-focused associations and has had elected and appointed executive positions in several. These include: Commercial Development and Marketing Association, Product Development and Marketing Association, Licensing Executives Society, The Conference Board, ASC, NHRA, AWWA, and several others including MENSA and Masons. In addition, he has had numerous articles published and each year makes many presentations at conferences on strategy, technology transfer, new business development, and his pioneering work on the concept of Voice of Market™. In addition he teaches courses and holds workshops on several topics.
Education includes a BS degree in Business Management from the University of Scranton and MBA courses at several different schools in addition to several semesters as professor at Wilmington College.
[back to top]
Scott Peterson
Mr. Peterson has practiced as an intellectual property attorney |
